Nomura Holdings’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,514
| Closed | -$198K | – | 1418 |
|
|
2024
Q4 | $198K | Buy |
+10,514
| New | +$198K | ﹤0.01% | 1385 |
|
|
2023
Q3 | – | Sell |
-130,040
| Closed | -$1.3M | – | 991 |
|
|
2023
Q2 | $1.3M | Sell |
130,040
-158,800
| -55% | -$1.59M | ﹤0.01% | 364 |
|
|
2023
Q1 | $2.56M | Buy |
288,840
+4,139
| +1% | +$36.8K | 0.01% | 364 |
|
|
2022
Q4 | $3.12M | Buy |
284,701
+46,497
| +20% | +$509K | 0.01% | 341 |
|
|
2022
Q3 | $3.1M | Sell |
238,204
-67,797
| -22% | -$883K | 0.01% | 392 |
|
|
2022
Q2 | $4.06M | Buy |
306,001
+661
| +0.2% | +$8.77K | 0.01% | 374 |
|
|
2022
Q1 | $4.27M | Buy |
305,340
+128,674
| +73% | +$1.8M | 0.01% | 392 |
|
|
2021
Q4 | $5.15M | Buy |
176,666
+80,316
| +83% | +$2.34M | 0.01% | 405 |
|
|
2021
Q3 | $3M | Buy |
96,350
+67,010
| +228% | +$2.08M | 0.01% | 515 |
|
|
2021
Q2 | $786K | Sell |
29,340
-99,900
| -77% | -$2.68M | ﹤0.01% | 808 |
|
|
2021
Q1 | $4.01M | Buy |
+129,240
| New | +$4.01M | 0.01% | 412 |
|